LDLR and metabolic dysfunction-associated steatohepatitis: In the present study, 40 LDLR(−/−) mice were fed a western-type diet to induce NASH and were subsequently treated with two different doses of AMP-DNM to achieve the dosing level of 50 and 100 mg AMP-DNM.